155 related articles for article (PubMed ID: 23831728)
1. Inhibition of methyleugenol bioactivation by the herb-based constituent nevadensin and prediction of possible in vivo consequences using physiologically based kinetic modeling.
Al-Subeihi AA; Alhusainy W; Paini A; Punt A; Vervoort J; van Bladeren PJ; Rietjens IM
Food Chem Toxicol; 2013 Sep; 59():564-71. PubMed ID: 23831728
[TBL] [Abstract][Full Text] [Related]
2. Identification of nevadensin as an important herb-based constituent inhibiting estragole bioactivation and physiology-based biokinetic modeling of its possible in vivo effect.
Alhusainy W; Paini A; Punt A; Louisse J; Spenkelink A; Vervoort J; Delatour T; Scholz G; Schilter B; Adams T; van Bladeren PJ; Rietjens IM
Toxicol Appl Pharmacol; 2010 Jun; 245(2):179-90. PubMed ID: 20226806
[TBL] [Abstract][Full Text] [Related]
3. Physiologically based kinetic modeling of bioactivation and detoxification of the alkenylbenzene methyleugenol in human as compared with rat.
Al-Subeihi AA; Spenkelink B; Punt A; Boersma MG; van Bladeren PJ; Rietjens IM
Toxicol Appl Pharmacol; 2012 May; 260(3):271-84. PubMed ID: 22445790
[TBL] [Abstract][Full Text] [Related]
4. Matrix-derived combination effect and risk assessment for estragole from basil-containing plant food supplements (PFS).
van den Berg SJ; Klaus V; Alhusainy W; Rietjens IM
Food Chem Toxicol; 2013 Dec; 62():32-40. PubMed ID: 23959103
[TBL] [Abstract][Full Text] [Related]
5. The natural basil flavonoid nevadensin protects against a methyleugenol-induced marker of hepatocarcinogenicity in male F344 rat.
Alhusainy W; Williams GM; Jeffrey AM; Iatropoulos MJ; Taylor S; Adams TB; Rietjens IM
Food Chem Toxicol; 2014 Dec; 74():28-34. PubMed ID: 25218219
[TBL] [Abstract][Full Text] [Related]
6. In vivo validation and physiologically based biokinetic modeling of the inhibition of SULT-mediated estragole DNA adduct formation in the liver of male Sprague-Dawley rats by the basil flavonoid nevadensin.
Alhusainy W; Paini A; van den Berg JH; Punt A; Scholz G; Schilter B; van Bladeren PJ; Taylor S; Adams TB; Rietjens IM
Mol Nutr Food Res; 2013 Nov; 57(11):1969-78. PubMed ID: 23894034
[TBL] [Abstract][Full Text] [Related]
7. Physiologically based biokinetic model of bioactivation and detoxification of the alkenylbenzene methyleugenol in rat.
Al-Subeihi AA; Spenkelink B; Rachmawati N; Boersma MG; Punt A; Vervoort J; van Bladeren PJ; Rietjens IM
Toxicol In Vitro; 2011 Feb; 25(1):267-85. PubMed ID: 20828604
[TBL] [Abstract][Full Text] [Related]
8. Identification of human and murine sulfotransferases able to activate hydroxylated metabolites of methyleugenol to mutagens in Salmonella typhimurium and detection of associated DNA adducts using UPLC-MS/MS methods.
Herrmann K; Engst W; Appel KE; Monien BH; Glatt H
Mutagenesis; 2012 Jul; 27(4):453-62. PubMed ID: 22337896
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the interindividual human variation in bioactivation of methyleugenol using physiologically based kinetic modeling and Monte Carlo simulations.
Al-Subeihi AA; Alhusainy W; Kiwamoto R; Spenkelink B; van Bladeren PJ; Rietjens IM; Punt A
Toxicol Appl Pharmacol; 2015 Mar; 283(2):117-26. PubMed ID: 25549870
[TBL] [Abstract][Full Text] [Related]
10. Urinary Methyleugenol-deoxyadenosine Adduct as a Potential Biomarker of Methyleugenol Exposure in Rats.
Feng Y; Wang S; Wang H; Peng Y; Zheng J
J Agric Food Chem; 2018 Feb; 66(5):1258-1263. PubMed ID: 29328669
[TBL] [Abstract][Full Text] [Related]
11. Basil extract inhibits the sulfotransferase mediated formation of DNA adducts of the procarcinogen 1'-hydroxyestragole by rat and human liver S9 homogenates and in HepG2 human hepatoma cells.
Jeurissen SM; Punt A; Delatour T; Rietjens IM
Food Chem Toxicol; 2008 Jun; 46(6):2296-302. PubMed ID: 18433972
[TBL] [Abstract][Full Text] [Related]
12. Human cytochrome p450 enzymes of importance for the bioactivation of methyleugenol to the proximate carcinogen 1'-hydroxymethyleugenol.
Jeurissen SM; Bogaards JJ; Boersma MG; ter Horst JP; Awad HM; Fiamegos YC; van Beek TA; Alink GM; Sudhölter EJ; Cnubben NH; Rietjens IM
Chem Res Toxicol; 2006 Jan; 19(1):111-6. PubMed ID: 16411663
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of methyleugenol in liver microsomes and primary hepatocytes: pattern of metabolites, cytotoxicity, and DNA-adduct formation.
Cartus AT; Herrmann K; Weishaupt LW; Merz KH; Engst W; Glatt H; Schrenk D
Toxicol Sci; 2012 Sep; 129(1):21-34. PubMed ID: 22610610
[TBL] [Abstract][Full Text] [Related]
14. Formation of hepatic DNA adducts by methyleugenol in mouse models: drastic decrease by Sult1a1 knockout and strong increase by transgenic human SULT1A1/2.
Herrmann K; Engst W; Meinl W; Florian S; Cartus AT; Schrenk D; Appel KE; Nolden T; Himmelbauer H; Glatt H
Carcinogenesis; 2014 Apr; 35(4):935-41. PubMed ID: 24318996
[TBL] [Abstract][Full Text] [Related]
15. Matrix modulation of the bioactivation of estragole by constituents of different alkenylbenzene-containing herbs and spices and physiologically based biokinetic modeling of possible in vivo effects.
Alhusainy W; van den Berg SJ; Paini A; Campana A; Asselman M; Spenkelink A; Punt A; Scholz G; Schilter B; Adams TB; van Bladeren PJ; Rietjens IM
Toxicol Sci; 2012 Sep; 129(1):174-87. PubMed ID: 22649189
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome P450 mediated bioactivation of methyleugenol to 1'-hydroxymethyleugenol in Fischer 344 rat and human liver microsomes.
Gardner I; Wakazono H; Bergin P; de Waziers I; Beaune P; Kenna JG; Caldwell J
Carcinogenesis; 1997 Sep; 18(9):1775-83. PubMed ID: 9328175
[TBL] [Abstract][Full Text] [Related]
17. Estragole DNA adduct accumulation in human liver HepaRG cells upon repeated in vitro exposure.
Yang S; Wesseling S; Rietjens IMCM
Toxicol Lett; 2021 Feb; 337():1-6. PubMed ID: 33189830
[TBL] [Abstract][Full Text] [Related]
18. Immunochemical detection of covalently modified protein adducts in livers of rats treated with methyleugenol.
Gardner I; Bergin P; Stening P; Kenna JG; Caldwell J
Chem Res Toxicol; 1996 Jun; 9(4):713-21. PubMed ID: 8831815
[TBL] [Abstract][Full Text] [Related]
19. Tandem mass spectrometry analysis of N2-(trans-Isoestragol-3'-yl)-2'-deoxyguanosine as a strategy to study species differences in sulfotransferase conversion of the proximate carcinogen 1'-hydroxyestragole.
Punt A; Delatour T; Scholz G; Schilter B; van Bladeren PJ; Rietjens IM
Chem Res Toxicol; 2007 Jul; 20(7):991-8. PubMed ID: 17590023
[TBL] [Abstract][Full Text] [Related]
20. A physiologically based biodynamic (PBBD) model for estragole DNA binding in rat liver based on in vitro kinetic data and estragole DNA adduct formation in primary hepatocytes.
Paini A; Punt A; Viton F; Scholz G; Delatour T; Marin-Kuan M; Schilter B; van Bladeren PJ; Rietjens IM
Toxicol Appl Pharmacol; 2010 May; 245(1):57-66. PubMed ID: 20144636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
